发现于翻译之中：药物研发的综合方法。

Found in translation: integrated approaches to drug development.

机构信息

Discipline of Medical Sciences, Faculty of Science and Technology, Queensland University of Technology, Brisbane, QLD 4001, Australia.

出版信息

Expert Rev Clin Pharmacol. 2011 Mar;4(2):207-9. doi: 10.1586/ecp.10.142.

DOI:10.1586/ecp.10.142

PMID:22115403

Abstract

The 44th Annual Scientific Meeting of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists; 'Found in translation: integrated approaches to drug development', was held in Melbourne, Australia, from 28 November to 1 December 2010. This was a wide-ranging conference that included some discussion of new drugs and new targets for drug development. The new drugs included dynamin inhibitors, Xen2174, an oxytocin receptor agonist and annexin-A12-26. The new targets included B7-dependent costimulation, chemoattractant receptors, granulocyte-macrophage colony-stimulating factor and glutathione peroxidases.

摘要

第 44 届澳大拉西亚临床和实验药理学家和毒理学家学会年会；“翻译中的发现：药物开发的综合方法”，于 2010 年 11 月 28 日至 12 月 1 日在澳大利亚墨尔本举行。这是一次范围广泛的会议，包括一些关于新药和药物开发新靶点的讨论。这些新药包括动力蛋白抑制剂、Xen2174、催产素受体激动剂和膜联蛋白-A12-26。新靶点包括 B7 依赖性共刺激、趋化因子受体、粒细胞-巨噬细胞集落刺激因子和谷胱甘肽过氧化物酶。